SORT1 and type 2 diabetes mellitus: The absolute quantification and percent exon inclusion results (Figure 4c) demonstrate that 8 nM of GLP1 is an optimal dose for reducing exon 17b inclusion into sortilin pre-mRNA in T2DM adipocytes.